Tigabu Kassa

Array ( [id] => 6189975 [patent_doc_number] => 20110172259 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-07-14 [patent_title] => 'DOSAGE FORM CONTAINING OXYCODONE AND NALOXONE' [patent_app_type] => utility [patent_app_number] => 12/945164 [patent_app_country] => US [patent_app_date] => 2010-11-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 56 [patent_figures_cnt] => 56 [patent_no_of_words] => 56215 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0172/20110172259.pdf [firstpage_image] =>[orig_patent_app_number] => 12945164 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5943652 [patent_doc_number] => 20110104272 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-05-05 [patent_title] => 'GASTRIC RETENTIVE EXTENDED-RELEASE DOSAGE FORMS COMPRISING COMBINATIONS OF ACETAMINOPHEN AND PHENYLEPHRINE' [patent_app_type] => utility [patent_app_number] => 12/940911 [patent_app_country] => US [patent_app_date] => 2010-11-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 16998 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0104/20110104272.pdf [firstpage_image] =>[orig_patent_app_number] => 12940911 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 16335527 [patent_doc_number] => 10786464 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-09-29 [patent_title] => Modified release formulation of lacosamide [patent_app_type] => utility [patent_app_number] => 13/505990 [patent_app_country] => US [patent_app_date] => 2010-11-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 5523 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 169 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13505990 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11428056 [patent_doc_number] => 09566360 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-02-14 [patent_title] => 'Fenton reaction catalyst using coffee grounds or tea dregs as raw material' [patent_app_type] => utility [patent_app_number] => 13/637139 [patent_app_country] => US [patent_app_date] => 2010-10-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 7 [patent_no_of_words] => 7242 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 186 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13637139 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5929735 [patent_doc_number] => 20110039694 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-02-17 [patent_title] => 'POLYMER BASED SEED COATING' [patent_app_type] => utility [patent_app_number] => 12/910345 [patent_app_country] => US [patent_app_date] => 2010-10-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1931 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0039/20110039694.pdf [firstpage_image] =>[orig_patent_app_number] => 12910345 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11611467 [patent_doc_number] => 09649311 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-05-16 [patent_title] => 'Solid pharmaceutical compositions containing an integrase inhibitor' [patent_app_type] => utility [patent_app_number] => 13/503939 [patent_app_country] => US [patent_app_date] => 2010-10-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 11322 [patent_no_of_claims] => 46 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 52 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13503939 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11561762 [patent_doc_number] => 09624334 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-04-18 [patent_title] => 'Hydrophilically-modified silicone compositions' [patent_app_type] => utility [patent_app_number] => 13/503639 [patent_app_country] => US [patent_app_date] => 2010-10-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 6 [patent_no_of_words] => 21008 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 239 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13503639 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8482926 [patent_doc_number] => 20120282333 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-11-08 [patent_title] => 'DELAYED RELEASE PHARMACEUTICAL COMPOSITION OF MESALAMINE' [patent_app_type] => utility [patent_app_number] => 13/502194 [patent_app_country] => US [patent_app_date] => 2010-10-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3406 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13502194 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6031228 [patent_doc_number] => 20110081416 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-04-07 [patent_title] => 'ORDERED MESOPOROUS SILICA MATERIAL' [patent_app_type] => utility [patent_app_number] => 12/905759 [patent_app_country] => US [patent_app_date] => 2010-10-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 42 [patent_figures_cnt] => 42 [patent_no_of_words] => 29488 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0081/20110081416.pdf [firstpage_image] =>[orig_patent_app_number] => 12905759 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6125174 [patent_doc_number] => 20110085969 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-04-14 [patent_title] => 'CHELATOR-TARGETING LIGAND CONJUGATES FOR CARDIOVASCULAR IMAGING' [patent_app_type] => utility [patent_app_number] => 12/900200 [patent_app_country] => US [patent_app_date] => 2010-10-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 18970 [patent_no_of_claims] => 66 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0085/20110085969.pdf [firstpage_image] =>[orig_patent_app_number] => 12900200 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8054241 [patent_doc_number] => 20120076859 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-03-29 [patent_title] => 'Targeted Lung Delivery of Citrulline and/or Another Nitric Oxide Precursor and a Method for Treatment of Pulmonary Deficiency of Nitric Oxide in Cystic Fibrosis and Other Pulmonary Diseases' [patent_app_type] => utility [patent_app_number] => 12/888729 [patent_app_country] => US [patent_app_date] => 2010-09-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14446 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0076/20120076859.pdf [firstpage_image] =>[orig_patent_app_number] => 12888729 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7817557 [patent_doc_number] => 20120064177 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-03-15 [patent_title] => 'METHOD OF PREPARING AN INTRANASAL COMPOSITION AND INTRANASAL COMPOSITIONS OBTAINABLE THEREBY' [patent_app_type] => utility [patent_app_number] => 12/879090 [patent_app_country] => US [patent_app_date] => 2010-09-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2081 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0064/20120064177.pdf [firstpage_image] =>[orig_patent_app_number] => 12879090 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8370205 [patent_doc_number] => 20120219597 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-08-30 [patent_title] => 'PHARMACEUTICAL FORMULATIONS FOR INDIBULIN' [patent_app_type] => utility [patent_app_number] => 13/392769 [patent_app_country] => US [patent_app_date] => 2010-09-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6103 [patent_no_of_claims] => 44 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13392769 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8416603 [patent_doc_number] => 20120244103 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-09-27 [patent_title] => 'REVERSIBLE ORAL ADHESIVE GEL' [patent_app_type] => utility [patent_app_number] => 13/394109 [patent_app_country] => US [patent_app_date] => 2010-08-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 7040 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13394109 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8445855 [patent_doc_number] => 08287904 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-10-16 [patent_title] => 'Stable soft capsule dosage form for acetylsalicylic acid' [patent_app_type] => utility [patent_app_number] => 12/859389 [patent_app_country] => US [patent_app_date] => 2010-08-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3834 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12859389 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11217735 [patent_doc_number] => 09446055 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-09-20 [patent_title] => 'Disintegrating particle composition and orally rapidly disintegrating tablet' [patent_app_type] => utility [patent_app_number] => 13/389880 [patent_app_country] => US [patent_app_date] => 2010-08-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9206 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 175 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13389880 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8200335 [patent_doc_number] => 20120123355 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-05-17 [patent_title] => 'ERODIBLE EMBOLIZATION MATERIAL' [patent_app_type] => utility [patent_app_number] => 13/387149 [patent_app_country] => US [patent_app_date] => 2010-07-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 4013 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0123/20120123355.pdf [firstpage_image] =>[orig_patent_app_number] => 13387149 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8227383 [patent_doc_number] => 20120141592 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-06-07 [patent_title] => 'CONTROLLED-RELEASE GRANULAR COMPOSITIONS CONTAINING MESALAZINE AND PROCESS FOR THE MANUFACTURE THEREOF' [patent_app_type] => utility [patent_app_number] => 13/388749 [patent_app_country] => US [patent_app_date] => 2010-07-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 5364 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13388749 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8184316 [patent_doc_number] => 20120114726 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-05-10 [patent_title] => 'INSECTICIDE-COATED SUBSTRATE FOR PROTECTING HUMANS AND PETS' [patent_app_type] => utility [patent_app_number] => 13/382694 [patent_app_country] => US [patent_app_date] => 2010-07-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7361 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0114/20120114726.pdf [firstpage_image] =>[orig_patent_app_number] => 13382694 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8171224 [patent_doc_number] => 20120107256 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-05-03 [patent_title] => 'Personal Care Emulsions Comprising Waxy Materials And Organopolysiloxanes' [patent_app_type] => utility [patent_app_number] => 13/381199 [patent_app_country] => US [patent_app_date] => 2010-06-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5405 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0107/20120107256.pdf [firstpage_image] =>[orig_patent_app_number] => 13381199 [rel_patent_id] =>[rel_patent_doc_number] =>)